Primary Care Provider Guide to Neonatal Abstinence Syndrome Follow UpPrimary Care Provider Guide to Neonatal Abstinence Syndrome Follow Up https://pediatricsnationwide.org/wp-content/themes/corpus/images/empty/thumbnail.jpg 150 150 Nationwide Children's Nationwide Children's https://secure.gravatar.com/avatar/8087ae3f73e51e24df5819a3363b55e0?s=96&d=mm&r=g
- October 22, 2018
- Nationwide Children's
Pediatricians have a unique challenge when it comes to caring for the broad spectrum of needs associated with opioid-exposed infants. Some babies who were treated with pharmacological methods in a hospital will be discharged home still on neuro-active medications. Other babies did not receive a neonatal abstinence syndrome (NAS) diagnosis or specific treatment after birth but are at high risk and may show signs of developmental problems. Nathalie Maitre, MD, PhD, director of the NICU Follow-up Program at Nationwide Children’s Hospital, and her team have developed two key algorithms to support the care of opioid-exposed infants.
You might also like
Teens on the Road: How Technology, Policy and Parents Influence Driving SafetyTeens on the Road: How Technology, Policy and Parents Influence Driving Safety https://pediatricsnationwide.org/wp-content/uploads/2021/10/Teens-on-Road-Feature-Art-crop-for-web-1024x633.jpg 1024 633 Abbie Roth Abbie Roth https://pediatricsnationwide.org/wp-content/uploads/2021/02/062019ds5821_abbie-profile-new.jpg
Risk for Serious Complications From Vaccine-Preventable Infections After Hematopoietic Cell TransplantRisk for Serious Complications From Vaccine-Preventable Infections After Hematopoietic Cell Transplant https://pediatricsnationwide.org/wp-content/uploads/2021/09/AdobeStock_443907137HRBW-1024x683.jpg 1024 683 Katie Brind'Amour, PhD, MS, CHES Katie Brind'Amour, PhD, MS, CHES https://pediatricsnationwide.org/wp-content/uploads/2021/03/Katie-B-portrait.gif